FILE PHOTO: Mounjaro is displayed in a pharmacy in Provo

FILE PHOTO: A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo

Post navigation

Previous: Eli Lilly is still seeking UK approval on pen for weight-loss drug

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Sign up for our free Bull Bear Daily Newsletter!

Discover new market trends and ideas directly to your inbox.

Search

You may have missed

Newsletters

Trump-era global funding cuts devastate HIV prevention programmes, UNAIDS says

Bull Bear Daily November 28, 2025 0

2025-11-26T064800Z_1_LYNXMPELAP07T_RTROPTP_4_UKRAINE-CRISIS-ATTACK-ZAPORIZHZHIA.JPG

Newsletters

Russian drones injure 19, cause extensive damage in Ukraine’s Zaporizhzhia

Bull Bear Daily November 28, 2025 0

Newsletters

Morning Bid: Will the Fed come to the rescue?

Bull Bear Daily November 28, 2025 0

2025-11-24T105337Z_2_LYNXMPELAN0B8_RTROPTP_4_GERMANY-DAILYLIFE-FRANKFURT.JPG

Newsletters

German business sentiment unexpectedly falls in November, Ifo survey finds

Bull Bear Daily November 27, 2025 0

Home
Privacy Policy
Terms of Service
Disclaimer
Contact Us

Home
Privacy Policy
Terms of Service
Disclaimer
Contact Us